Prometheus Settles Lawsuit Vs. Specialty Labs Over Gastrointestinal Assay

Law360, New York (August 13, 2004, 12:00 AM EDT) -- Specialty pharmaceutical company Prometheus Laboratories Inc. has settled its lawsuit against rival Specialty Laboratories, Inc. in a deal under which Specialty has agreed not market an assay developed for the treatment of gastrointestinal disorders and autoimmune diseases.

As part of the settlement, Specialty has agreed not to use, offer or sell its 6-MP Drug MonitR assay, Prometheus said in a statement.

Prometheus sued Specialty in the U.S. District Court for the Southern District of California in June of this year, alleging that the use or sale...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.